140 related articles for article (PubMed ID: 35117154)
1. Identification of the differentially expressed proteins in nasopharyngeal carcinoma by proteomics.
Rong D; Lin X; Luo Y; Mok TS; Wang Q; Wang H; Zhang T
Transl Cancer Res; 2020 Jan; 9(1):21-29. PubMed ID: 35117154
[TBL] [Abstract][Full Text] [Related]
2. SWATH-based proteomics identified carbonic anhydrase 2 as a potential diagnosis biomarker for nasopharyngeal carcinoma.
Luo Y; Mok TS; Lin X; Zhang W; Cui Y; Guo J; Chen X; Zhang T; Wang T
Sci Rep; 2017 Jan; 7():41191. PubMed ID: 28117408
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the differential secretome of nasopharyngeal carcinoma cell lines CNE-2R and CNE-2.
Chen ZT; Li L; Guo Y; Qu S; Zhao W; Chen H; Su F; Yin J; Mo QY; Zhu XD
Oncol Rep; 2015 Nov; 34(5):2477-88. PubMed ID: 26352878
[TBL] [Abstract][Full Text] [Related]
4. Low-molecular-mass secretome profiling identifies C-C motif chemokine 5 as a potential plasma biomarker and therapeutic target for nasopharyngeal carcinoma.
Lin SJ; Chang KP; Hsu CW; Chi LM; Chien KY; Liang Y; Tsai MH; Lin YT; Yu JS
J Proteomics; 2013 Dec; 94():186-201. PubMed ID: 24080422
[TBL] [Abstract][Full Text] [Related]
5. Applying 'Sequential Windowed Acquisition of All Theoretical Fragment Ion Mass Spectra' (SWATH) for systematic toxicological analysis with liquid chromatography-high-resolution tandem mass spectrometry.
Arnhard K; Gottschall A; Pitterl F; Oberacher H
Anal Bioanal Chem; 2015 Jan; 407(2):405-14. PubMed ID: 25366975
[TBL] [Abstract][Full Text] [Related]
6. Identification of candidate biomarkers for the early detection of nasopharyngeal carcinoma by quantitative proteomic analysis.
Yang J; Zhou M; Zhao R; Peng S; Luo Z; Li X; Cao L; Tang K; Ma J; Xiong W; Fan S; Schmitt DC; Tan M; Li X; Li G
J Proteomics; 2014 Sep; 109():162-75. PubMed ID: 24998431
[TBL] [Abstract][Full Text] [Related]
7. Proteome profiling of Epstein-Barr virus infected nasopharyngeal carcinoma cell line: identification of potential biomarkers by comparative iTRAQ-coupled 2D LC/MS-MS analysis.
Feng X; Zhang J; Chen WN; Ching CB
J Proteomics; 2011 Apr; 74(4):567-76. PubMed ID: 21296196
[TBL] [Abstract][Full Text] [Related]
8. Coupling of Cell Surface Biotinylation and SILAC-Based Quantitative Proteomics Identified Myoferlin as a Potential Therapeutic Target for Nasopharyngeal Carcinoma Metastasis.
Li M; Peng F; Wang G; Liang X; Shao M; Chen Z; Chen Y
Front Cell Dev Biol; 2021; 9():621810. PubMed ID: 34178975
[TBL] [Abstract][Full Text] [Related]
9. Identification of radioresistance-associated proteins in human nasopharyngeal carcinoma cell lines by proteomic analysis.
Li L; Huang S; Zhu X; Zhou Z; Liu Y; Qu S; Guo Y
Cancer Biother Radiopharm; 2013 Jun; 28(5):380-4. PubMed ID: 23464856
[TBL] [Abstract][Full Text] [Related]
10. Optimization of Acquisition and Data-Processing Parameters for Improved Proteomic Quantification by Sequential Window Acquisition of All Theoretical Fragment Ion Mass Spectrometry.
Li S; Cao Q; Xiao W; Guo Y; Yang Y; Duan X; Shui W
J Proteome Res; 2017 Feb; 16(2):738-747. PubMed ID: 27995803
[TBL] [Abstract][Full Text] [Related]
11. Identification of nasopharyngeal carcinoma metastasis-related biomarkers by iTRAQ combined with 2D-LC-MS/MS.
Chen Z; Long L; Wang K; Cui F; Zhu L; Tao Y; Wu Q; Xiang M; Liang Y; Qiu S; Xiao Z; Yi B
Oncotarget; 2016 Jun; 7(23):34022-37. PubMed ID: 27145374
[TBL] [Abstract][Full Text] [Related]
12. Identification of differentially expressed circular RNAs in human nasopharyngeal carcinoma.
Wu H; Liu Y; Duan H; Fan X; Wang Y; Song J; Han J; Yang M; Lu L; Nie G
Cancer Biomark; 2020; 29(4):483-492. PubMed ID: 32865182
[TBL] [Abstract][Full Text] [Related]
13. Quantitative plasma proteome analysis reveals aberrant level of blood coagulation-related proteins in nasopharyngeal carcinoma.
Peng PH; Wu CC; Liu SC; Chang KP; Chen CD; Chang YT; Hsu CW; Chang YS; Yu JS
J Proteomics; 2011 May; 74(5):744-57. PubMed ID: 21376147
[TBL] [Abstract][Full Text] [Related]
14. [Screening for differentially expressed proteins in nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis].
Yi H; Cheng AL; Huang WG; Zhang PF; Li MY; Peng F; Li F; Li C; Chen ZC; Xiao ZQ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 May; 33(5):375-83. PubMed ID: 18544839
[TBL] [Abstract][Full Text] [Related]
15. iTRAQ-based quantitative proteomic analysis of differentially expressed proteins in chemoresistant nasopharyngeal carcinoma.
Wang K; Chen Z; Long L; Tao Y; Wu Q; Xiang M; Liang Y; Xie X; Jiang Y; Xiao Z; Yan Y; Qiu S; Yi B
Cancer Biol Ther; 2018; 19(9):809-824. PubMed ID: 30067426
[TBL] [Abstract][Full Text] [Related]
16. Next Generation Proteomics for Clinical Biomarker Detection Using SWATH-MS.
Lin Q; Tan HT; Chung MCM
Methods Mol Biol; 2019; 1977():3-15. PubMed ID: 30980318
[TBL] [Abstract][Full Text] [Related]
17. [Comparative proteomics of the serum in patients with nasopharyngeal carcinoma: a study with two-dimensional electrophoresis and MALDI-TOF-MS].
Liao QL; Chen XD; Zhao L; Ding YQ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):154-8. PubMed ID: 18250030
[TBL] [Abstract][Full Text] [Related]
18. iTRAQ-Based Quantitative Proteomic Analysis of Nasopharyngeal Carcinoma.
Cai XZ; Zeng WQ; Xiang Y; Liu Y; Zhang HM; Li H; She S; Yang M; Xia K; Peng SF
J Cell Biochem; 2015 Jul; 116(7):1431-41. PubMed ID: 25648846
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis of docetaxel resistance in human nasopharyngeal carcinoma cells using the two-dimensional gel electrophoresis method.
Peng X; Gong FM; Ren M; Ai P; Wu S; Tang J; Hu X
Anticancer Drugs; 2016 Sep; 27(8):748-55. PubMed ID: 27333594
[TBL] [Abstract][Full Text] [Related]
20. SWATH mass spectrometry as a tool for quantitative profiling of the matrisome.
Krasny L; Bland P; Kogata N; Wai P; Howard BA; Natrajan RC; Huang PH
J Proteomics; 2018 Oct; 189():11-22. PubMed ID: 29501709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
